Tian M & Schiemann WP TGF-ß Stimulation of EMT Programs Elicits Non-genomic ER-a Activity and Anti-estrogen Resistance in Breast Cancer Cells.J Cancer Metastasis Treat 3:150-160 (2017).
Stock K et al.Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery.Sci Rep 6:28951 (2016).
Joseph JD et al.The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.Elife 5:N/A (2016).
Kangaspeska S et al.Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer.BMC Cancer 16:378 (2016).
Cheang TY et al.C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.J Transl Med 14:54 (2016).
Overcast WB et al.Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study.Virchows Arch 469:203-12 (2016).
Lee JK et al.Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells.Front Cell Dev Biol 3:13 (2015).
Shah SH et al.Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype.Cancer Biol Ther 16:1671-81 (2015).
Xia X et al.PAX6 overexpression is associated with the poor prognosis of invasive ductal breast cancer.Oncol Lett 10:1501-1506 (2015).
Holmström O et al.Quantification of Estrogen Receptor-Alpha Expression in Human Breast Carcinomas With a Miniaturized, Low-Cost Digital Microscope: A Comparison with a High-End Whole Slide-Scanner.PLoS One 10:e0144688 (2015).
Coudyzer P et al.Induction of post-menstrual regeneration by ovarian steroid withdrawal in the functionalis of xenografted human endometrium.Hum Reprod 30:1156-68 (2015).
Park SY et al.Does background parenchymal enhancement on MRI affect the rate of positive resection margin in breast cancer patients?Br J Radiol 88:20140638 (2015).
Varghese F et al.IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples.PLoS One 9:e96801 (2014).
Pape-Zambito D et al.Identifying a Highly-Aggressive DCIS Subgroup by Studying Intra-Individual DCIS Heterogeneity among Invasive Breast Cancer Patients.PLoS One 9:e100488 (2014).
Babayan A et al.Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients.PLoS One 8:e75038 (2013).
Huang Z et al.Development of new rabbit monoclonal antibody to estrogen receptor: immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue sections.Appl Immunohistochem Mol Morphol 13:91-5 (2005).
Cano G et al.Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.Diagn Cytopathol 29:207-11 (2003).